These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29189675)

  • 1. Increasing Linezolid-resistant Enterococcus in a Children's Hospital.
    Bagga B; Buckingham S; Arnold S; Nesbitt A; Guimera D; Lee K
    Pediatr Infect Dis J; 2018 Mar; 37(3):242-244. PubMed ID: 29189675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of mechanisms and molecular epidemiology of linezolid nonsusceptible Enterococcus faecalis isolated from a teaching hospital in China.
    Li B; Ma CL; Yu X; Sun Y; Li MM; Ye JZ; Zhang YP; Wu Q; Zhou TL
    J Microbiol Immunol Infect; 2016 Aug; 49(4):595-9. PubMed ID: 26210761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of linezolid as assessed through the 2013 LEADER surveillance program.
    Flamm RK; Mendes RE; Hogan PA; Ross JE; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2015 Apr; 81(4):283-9. PubMed ID: 25633420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of hospital-acquired linezolid-nonsusceptible enterococci infection in Chongqing, China, 2011-2014.
    Jia X; Ma W; Xu X; Yang S; Zhang L
    Am J Infect Control; 2015 Dec; 43(12):e101-6. PubMed ID: 26315061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empyema thoracis caused by an optrA-positive and linezolid-intermediate Enterococcus faecalis strain.
    Chien JY; Mendes RE; Deshpande LM; Hsueh PR
    J Infect; 2017 Aug; 75(2):182-184. PubMed ID: 28506787
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk factors and outcomes associated with vancomycin-resistant Enterococcus infections with reduced susceptibilities to linezolid.
    Santayana EM; Grim SA; Janda WM; Layden JE; Lee TA; Clark NM
    Diagn Microbiol Infect Dis; 2012 Sep; 74(1):39-42. PubMed ID: 22749382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms.
    Chen H; Wu W; Ni M; Liu Y; Zhang J; Xia F; He W; Wang Q; Wang Z; Cao B; Wang H
    Int J Antimicrob Agents; 2013 Oct; 42(4):317-21. PubMed ID: 23880167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of optrA-positive enterococci clinical isolates in Belgium.
    Argudín MA; Youzaga S; Dodémont M; Heinrichs A; Roisin S; Deplano A; Nonhoff C; Hallin M
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):985-987. PubMed ID: 30771123
    [No Abstract]   [Full Text] [Related]  

  • 9. Activity of vancomycin, linezolid, and daptomycin against staphylococci and enterococci isolated in 5 Greek hospitals during a 5-year period (2008-2012).
    Papadimitriou-Olivgeris M; Kolonitsiou F; Zerva L; Lebessi E; Koutsia C; Drougka E; Sarrou S; Giormezis N; Vourli S; Doudoulakakis A; Konsolakis C; Marangos M; Anastassiou ED; Petinaki E; Spiliopoulou I
    Diagn Microbiol Infect Dis; 2015 Dec; 83(4):386-8. PubMed ID: 26341703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and antimicrobial susceptibility pattern of Enterococcus species isolated from different clinical samples at Black Lion Specialized Teaching Hospital, Addis Ababa, Ethiopia.
    Ferede ZT; Tullu KD; Derese SG; Yeshanew AG
    BMC Res Notes; 2018 Nov; 11(1):793. PubMed ID: 30400980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged linezolid use is associated with the development of linezolid-resistant Enterococcus faecium.
    Smith TT; Tamma PD; Do TB; Dzintars KE; Zhao Y; Cosgrove SE; Avdic E
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):161-163. PubMed ID: 29496381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors associated with linezolid-nonsusceptible enterococcal infections.
    McGregor JC; Hartung DM; Allen GP; Taplitz RA; Traver R; Tong T; Bearden DT
    Am J Infect Control; 2012 Nov; 40(9):886-7. PubMed ID: 22361358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of vancomycin-resistant enterococci in Canadian hospitals (CANWARD study, 2007 to 2013).
    Simner PJ; Adam H; Baxter M; McCracken M; Golding G; Karlowsky JA; Nichol K; Lagacé-Wiens P; Gilmour MW; ; Hoban DJ; Zhanel GG
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4315-7. PubMed ID: 25896693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of a cfr(B) Variant in German Enterococcus faecium Clinical Isolates and the Impact on Linezolid Resistance in Enterococcus spp.
    Bender JK; Fleige C; Klare I; Fiedler S; Mischnik A; Mutters NT; Dingle KE; Werner G
    PLoS One; 2016; 11(11):e0167042. PubMed ID: 27893790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the classical G2576U mutation in linezolid resistant Staphylococcus aureus along with isolation of linezolid resistant Enterococcus faecium from a patient on short-term linezolid therapy: first report from India.
    Rai S; Niranjan DK; Kaur T; Singh NP; Hada V; Kaur IR
    Indian J Med Microbiol; 2015; 33(1):21-4. PubMed ID: 25559997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-infection with three linezolid-resistant Enterococcus faecium ST117 strain variants: what are we missing in diagnosis?
    Freitas AR; Novais C; Read A; Alves V; Peixe L
    Int J Antimicrob Agents; 2016 Jun; 47(6):500-1. PubMed ID: 27179813
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigation of mechanism and molecular epidemiology of linezolid-resistant Enterococcus faecalis in China.
    Wang L; He Y; Xia Y; Wang H; Liang S
    Infect Genet Evol; 2014 Aug; 26():14-9. PubMed ID: 24815727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose Optimization of Combined Linezolid and Fosfomycin against
    Mao J; Li T; Zhang N; Wang S; Li Y; Peng Y; Liu H; Yang G; Yan Y; Jiang L; Liu Y; Li J; Huang X
    Microbiol Spectr; 2021 Dec; 9(3):e0087121. PubMed ID: 34851157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enterococci With Special Resistance Patterns - Epidemiology, Hygiene and Therapy].
    Mischnik A; Werner G; Bender J; Mutters NT
    Dtsch Med Wochenschr; 2019 Apr; 144(8):553-560. PubMed ID: 30986864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
    Seedat J; Zick G; Klare I; Konstabel C; Weiler N; Sahly H
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.